Risk of myocarditis and pericarditis following coronavirus disease 2019 messenger RNA Vaccination—A nationwide study

Risk of myocarditis and pericarditis following coronavirus disease 2019 messenger RNA Vaccination—A nationwide study

Background: An extended interval between the two primary doses may reduce the risk of myocarditis/pericarditis after COVID-19 mRNA vaccination. Taiwan has implemented a two-dose regimen with a 12-week interval for adolescents. Here we present nationwide data of myocarditis/pericarditis following COV...

Full description

Bibliographic Details
Main Authors:	Wei-Ju Su, Yu-Lun Liu, Chia-Hsuin Chang, Yen-Ching Lin, Wei-I Huang, Li-Chiu Wu, Shu-Fong Chen, Yu-Sheng Lin, Yee-Lin Hsieh, Chiao-An Yang, Chiu-Hsiang Lin, Kim-Wei Arnold Chan, Ping-Ing Lee, Jen-Hsiang Chuang, Chin-Hui Yang
Format:	Article
Language:	English
Published:	Elsevier 2023-06-01
Series:	Journal of Microbiology, Immunology and Infection
Subjects:	COVID-19 Vaccination Myocarditis Pericarditis Population-based study
Online Access:	http://www.sciencedirect.com/science/article/pii/S168411822300035X

Similar Items

COVID-19 Vaccine-Induced Myocarditis and Pericarditis: Towards Identification of Risk Factors
by: Laura C. Zwiers, et al.
Published: (2023-07-01)

Correction: COVID-19 Vaccine-Induced Myocarditis and Pericarditis: Towards Identification of Risk Factors
by: Laura C. Zwiers, et al.
Published: (2024-01-01)

Myocarditis or Pericarditis Following the COVID-19 Vaccination in Adolescents: A Systematic Review
by: Minglong Li, et al.
Published: (2022-08-01)

Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: What Do We Know So Far?
by: Bibhuti B. Das, et al.
Published: (2021-07-01)

Myocarditis and pericarditis in young patients following Campylobacter jejuni enterocolitis infection: a systematic review of case studies
by: Katharine Sanicola, et al.
Published: (2024-11-01)

Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand
by: Chayanit Mahasing, et al.
Published: (2023-03-01)

Myocarditis/pericarditis following vaccination with BNT162b2, CoronaVac, and ChAdOx1 among adolescent and adult in Malaysia
by: Norazida Ab Rahman, et al.
Published: (2023-08-01)

Pericarditis due to an unusual microorganismin an immunocompromised patient
by: Flora Özkalaycı, et al.
Published: (2019-09-01)

Disentangling a Thorny Issue: Myocarditis and Pericarditis Post COVID-19 and Following mRNA COVID-19 Vaccines
by: Concetta Rafaniello, et al.
Published: (2022-04-01)

Causal relationship between COVID-19 and myocarditis or pericarditis risk: a bidirectional Mendelian randomization study
by: Guihong Liu, et al.
Published: (2023-12-01)

Shedding the Light on Post-Vaccine Myocarditis and Pericarditis in COVID-19 and Non-COVID-19 Vaccine Recipients
by: Rima Hajjo, et al.
Published: (2021-10-01)

The incidence and clinical characteristics of myocarditis and pericarditis following mRNA-based COVID-19 vaccination in Republic of Korea adolescents from July 2021 to September 2022
by: Ju-Young Sim, et al.
Published: (2023-04-01)

Purulent Bacterial Pericarditis
by: Emily S. Lee, MD, et al.
Published: (2024-04-01)

A Pharmacoepidemiological Study of Myocarditis and Pericarditis Following the First Dose of mRNA COVID-19 Vaccine in Europe
by: Joana Tome, et al.
Published: (2023-04-01)

Life-threatening constrictive pericarditis accompanied by synthetic cannabinoid use: A case report and literature review
by: Mahsa Behnemoon, et al.
Published: (2024-07-01)

Risk of Myocarditis and Pericarditis among Young Adults following mRNA COVID-19 Vaccinations
by: Abdallah Alami, et al.
Published: (2022-05-01)

Myocarditis and pericarditis in individuals exposed to the Ad26.COV2.S, BNT162b2 mRNA, or mRNA-1273 SARS-CoV-2 vaccines
by: Manan Pareek, et al.
Published: (2023-11-01)

Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries
by: Sophie H. Bots, et al.
Published: (2022-11-01)

Risk of Coronavirus Disease 2019 Messenger RNA Vaccination-Associated Myocarditis and Pericarditis – A Systematic Review of Population-Based Data
by: Lin YC, et al.
Published: (2023-10-01)

EXPERIMENTAL PERICARDITIS
by: E.A. LOZOVSKAYA, et al.
Published: (2023-12-01)

Tuberculous Pericarditis—Own Experiences and Recent Recommendations
by: Małgorzata Dybowska, et al.
Published: (2022-03-01)

Infectious-immune pericarditis: clinical assessment, diagnostics, and differentiated baseline therapy with hydroxychloroquine
by: O. V. Blagova, et al.
Published: (2020-12-01)

Booster dose of COVID-19 mRNA vaccine does not increase risks of myocarditis and pericarditis compared with primary vaccination: New insights from the vaccine adverse event reporting system
by: Congqin Chen, et al.
Published: (2022-09-01)

Pericarditis Purulenta
by: Máximo Rossell Salinas
Published: (1992-06-01)

The association of myocardial strain with cardiac magnetic resonance and clinical outcomes in patients with acute myocarditis
by: Alexandre M. Soeiro, et al.
Published: (2023-07-01)

COVID-19 VACCINE-ASSOCIATED MYOCARDITIS (RUSSIAN TRANSLATION)
by: M. C. Morgan, et al.
Published: (2022-12-01)

A multiprovincial retrospective analysis of the incidence of myocarditis or pericarditis after mRNA vaccination compared to the incidence after SARS-CoV-2 infection
by: Zaeema Naveed, et al.
Published: (2024-03-01)

Fibrinolytic Therapy in Purulent Pericarditis
by: Małgorzata Dybowska, et al.
Published: (2023-01-01)

Purulent pericarditis as a complication of pneumonia in an infant. Clinical case report
by: Diego Alejandro Lozano Espinosa, et al.
Published: (2018-01-01)

Pericarditis Purulenta en un postoperado de Colecistectomía .Presentación de caso Purulent pericarditis in a postoperative cholecystectomy. Case presentation
by: Carlos Enrique Salgado Fuentes, et al.
Published: (2021-01-01)

Surgical Treatment of Constrictive Pericarditis
by: Brunella Bertazzo, et al.
Published: (2023-01-01)

Pericarditis: Are There Any Changes Since 1761? A Panoramic View of Pericarditis
by: Deniz Elcik, et al.
Published: (2019-09-01)

Shortening of the PR interval in pericarditis after coronary bypass surgery
by: David P. Dundua, et al.
Published: (2022-07-01)

Unraveling Heart Inflammation: Recurrent Myopericarditis Caused by Coxsackie A Virus—A Case Report
by: Maisha Maliha, et al.
Published: (2024-12-01)

Purulent Pericarditis in an Immunocompetent Young Child
by: Şeyma Şebnem Ön, et al.
Published: (2024-09-01)

Melioidosis and the Heart: A Systematic Review
by: Ragani Velusamy, et al.
Published: (2020-07-01)

Myopericarditis caused by severe acute respiratory syndrome coronavirus 2
by: İbrahim Ulaş Özturan, et al.
Published: (2020-12-01)

Post –acute sequalae of COVID-19 and cardiac outcomes in U. S. military members
by: Sithembile Mabila, et al.
Published: (2023-06-01)

Clinical Presentation of Pediatric Myocarditis in Taiwan
by: Hsiang-Ju Hsiao, et al.
Published: (2011-06-01)

Disseminated tuberculosis with purulent effusive-constrictive pericarditis
by: Rolando A. Zamora Gonzalez, et al.
Published: (2023-01-01)